A review of international medical device regulations: Contact lenses and lens care solutions
Files in This Item:
|Peer Reviewed Author Draft Medical Device Contact Lenses Paper.pdf||555.08 kB||Adobe PDF||Download|
|Title:||A review of international medical device regulations: Contact lenses and lens care solutions||Authors:||Zaki, Marina; Pardo, Jesús; Carracedo, Gonzalo||Permanent link:||http://hdl.handle.net/10197/9613||Date:||Apr-2019||Online since:||2019-02-26T14:48:03Z||Abstract:||Medical devices are under strict regulatory oversight worldwide and such regulations prioritise patient safety and efficacy over anything else. Contact lenses fall under the medical device category - a result of direct contact with the eye. Equally regulated are the contact lens care product solutions, which include cleaning and maintenance solutions and lubricating and rewetting drops. In the USA, it is the FDA Centre for Devices and Radiological Health (CDRH) overseeing the regulations of medical devices, since 1976. In the European Union, it is the EU Commission responsible for regulating devices in Member States. The categorisation of contact lenses into medical devices is based on their inherent risk to the wearer. Contact lenses are subject to crucial regulatory oversight from concept to clinical evaluation, clinical investigations through to the finished lens product, and finally, strict conditions associated with their marketing approval including post-marketing surveillance. The physiochemical and manufacturing testing, such as biocompatibility testing alongside pre-clinical stability, sterility and microbiological testing are just some of the essential testing lenses must endure. Only through understanding the inherent risks and potential complications that can arise from contact lens wear, can one truly appreciate the need to adhere to strict regulations. The challenge however, lies in the need for more standardised regulations and flexible approaches, ensuring innovative device technologies reach patients in a timely manner without compromising public health and safety. This review highlights some key requirement, differences and similarities between the FDA and EU administrations in the approval of contact lenses.||Funding Details:||European Commission Horizon 2020||Type of material:||Journal Article||Publisher:||Elsevier||Journal:||Contact Lens and Anterior Eye||Volume:||42||Issue:||2||Start page:||136||End page:||146||Copyright (published version):||2018 British Contact Lens Association||Keywords:||Clinical investigation; Market approval; Contact lenses; Care solutions; Clinical evaluation||DOI:||10.1016/j.clae.2018.11.001||Language:||en||Status of Item:||Peer reviewed|
|Appears in Collections:||Conway Institute Research Collection|
Biomolecular and Biomedical Science Research Collection
Show full item record
This item is available under the Attribution-NonCommercial-NoDerivs 3.0 Ireland. No item may be reproduced for commercial purposes. For other possible restrictions on use please refer to the publisher's URL where this is made available, or to notes contained in the item itself. Other terms may apply.